474 related articles for article (PubMed ID: 33639496)
21. Assessment of tumor morphology on diffusion-weighted (DWI) breast MRI: Diagnostic value of reduced field of view DWI.
Barentsz MW; Taviani V; Chang JM; Ikeda DM; Miyake KK; Banerjee S; van den Bosch MA; Hargreaves BA; Daniel BL
J Magn Reson Imaging; 2015 Dec; 42(6):1656-65. PubMed ID: 25914178
[TBL] [Abstract][Full Text] [Related]
22. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
[TBL] [Abstract][Full Text] [Related]
23. How to manage type 2 curve dilemma in dynamic contrast-enhanced magnetic resonance imaging of the breast: diffusion-weighted imaging or early phase enhancement kinetics?
Ulu Öztürk F; Tezcan Ş; Uslu N
Acta Radiol; 2024 Apr; 65(4):341-349. PubMed ID: 38193154
[TBL] [Abstract][Full Text] [Related]
24. Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.
Ma D; Lu F; Zou X; Zhang H; Li Y; Zhang L; Chen L; Qin D; Wang B
Magn Reson Imaging; 2017 Feb; 36():175-179. PubMed ID: 27742437
[TBL] [Abstract][Full Text] [Related]
25. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
26. Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.
Zhou J; Chen E; Xu H; Ye Q; Li J; Ye S; Cheng Q; Zhao L; Su MY; Wang M
J Magn Reson Imaging; 2019 Jun; 49(6):1610-1616. PubMed ID: 30328211
[TBL] [Abstract][Full Text] [Related]
27. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient.
Cao Y; Wang X; Shi J; Zeng X; Du L; Li Q; Nickel D; Zhou X; Zhang J
Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225
[TBL] [Abstract][Full Text] [Related]
28. Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS.
Gao W; Zhang S; Guo J; Wei X; Li X; Diao Y; Huang W; Yao Y; Shang A; Zhang Y; Yang Q; Chen X
J Magn Reson Imaging; 2021 Apr; 53(4):1118-1127. PubMed ID: 33179809
[TBL] [Abstract][Full Text] [Related]
29. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
[TBL] [Abstract][Full Text] [Related]
30. Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study.
Pinker K; Baltzer P; Bogner W; Leithner D; Trattnig S; Zaric O; Dubsky P; Bago-Horvath Z; Rudas M; Gruber S; Weber M; Helbich TH
Radiology; 2015 Aug; 276(2):360-70. PubMed ID: 25751227
[TBL] [Abstract][Full Text] [Related]
31. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value.
Partridge SC; DeMartini WB; Kurland BF; Eby PR; White SW; Lehman CD
AJR Am J Roentgenol; 2009 Dec; 193(6):1716-22. PubMed ID: 19933670
[TBL] [Abstract][Full Text] [Related]
32. Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI.
Saccenti L; Mellon CM; Scholer M; Jolibois Z; Stemmer A; Weiland E; de Bazelaire C
Diagn Interv Imaging; 2023 Sep; 104(9):410-418. PubMed ID: 37208291
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of malignant and benign breast lesions: Added value of the qualitative analysis of breast lesions on diffusion-weighted imaging (DWI) using readout-segmented echo-planar imaging at 3.0 T.
An YY; Kim SH; Kang BJ
PLoS One; 2017; 12(3):e0174681. PubMed ID: 28358833
[TBL] [Abstract][Full Text] [Related]
34. Breast lesion morphology assessment with high and standard b values in diffusion-weighted imaging at 3 Tesla.
Christner SA; Grunz JP; Schlaiß T; Curtaz C; Kunz AS; Huflage H; Patzer TS; Bley TA; Sauer ST
Magn Reson Imaging; 2024 Apr; 107():100-110. PubMed ID: 38246517
[TBL] [Abstract][Full Text] [Related]
35. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
36. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
[TBL] [Abstract][Full Text] [Related]
37. Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions.
Yang X; Dong M; Li S; Chai R; Zhang Z; Li N; Zhang L
Eur Radiol; 2020 Sep; 30(9):4795-4805. PubMed ID: 32350660
[TBL] [Abstract][Full Text] [Related]
38. A multiparametric approach to diagnosing breast lesions using diffusion-weighted imaging and ultrafast dynamic contrast-enhanced MRI.
Ohashi A; Kataoka M; Iima M; Kanao S; Honda M; Urushibata Y; Nickel MD; Kishimoto AO; Ota R; Toi M; Togashi K
Magn Reson Imaging; 2020 Sep; 71():154-160. PubMed ID: 32302738
[TBL] [Abstract][Full Text] [Related]
39. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
[TBL] [Abstract][Full Text] [Related]
40. Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI.
Tan SL; Rahmat K; Rozalli FI; Mohd-Shah MN; Aziz YF; Yip CH; Vijayananthan A; Ng KH
Clin Radiol; 2014 Jan; 69(1):63-71. PubMed ID: 24156797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
